Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-18-011592

SVP & Chief Financial Officer sold 3,477 shares at $82.94 ($288,382)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Labrucherie Gil M SVP & Chief Financial Officer 2018-02-16 Sale −3,477 $82.94 $288,382 99,739 D: show line 1 in the form
Open-market sales · 3,477 sh · avg $82.94 · $288,382
Loading xslF345X03/doc4.xml…